IM Cannabis (IMCC) FCF Payout Ratio (2020 - 2026)
IM Cannabis (IMCC) posted quarterly FCF Payout Ratio of 5.55 for Q1 2026, down 1882.3% year-over-year from 0.31 in Q1 2025, and down 1882.3% quarter-over-quarter from 0.31 in Q1 2025.
IM Cannabis (IMCC) FCF Payout Ratio (2020 - 2026) Analysis & Trends
IM Cannabis' FCF Payout Ratio history runs 7 years deep, the most recent figure standing at 5.55 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.85 Bn | 39.19 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.40 Bn | 29.73 Bn | 1.05 Bn | 0.41 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.83 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 0.42 |
| 7 | Neurocrine Biosciences | 15.42 Bn | 15.03 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | IM Cannabis | 539,904.01 | -629,066.16 | 1.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.55 |
| Mar 31, 2025 | 0.31 |
| Sep 30, 2024 | 0.44 |
| Jun 30, 2024 | -0.33 |
| Mar 31, 2024 | -1.67 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | -0.25 |
| Sep 30, 2022 | 1.13 |
| Jun 30, 2022 | 4.08 |
| Mar 31, 2022 | -1.18 |
| Sep 30, 2021 | 0.80 |
| Jun 30, 2021 | -2.29 |
| Mar 31, 2021 | -0.18 |
| Mar 31, 2020 | -10.11 |